Literature DB >> 9388234

Functional interaction between the DNA binding subunit trimerization domain of NF-Y and the high mobility group protein HMG-I(Y).

R A Currie1.   

Abstract

The mammalian transcription factor, NF-Y(CBF), contains three known subunit components, NF-YA (CBF-B), NF-YB(CBF-A), and NF-YC(CBF-C), which are all required to reconstitute specific CCAAT box DNA binding activity. In this study, the high mobility group chromosomal protein, HMG-I(Y), has been shown to activate NF-Y in transient transfections in vivo using the natural murine alpha2(I) collagen promoter and a multimerized version of the proximal NF-Y(CBF) CCAAT box element. In vitro analysis of the alpha2(I) collagen promoter region inclusive of the NF-Y(CBF) binding site (-106 to -65 base pairs) failed to identify any high affinity HMG-I(Y) DNA-binding sites. However, the heterotrimeric NF-Y complex, as well as the NF-YA subunit alone, was shown to stably interact in vitro with both HMG-I(Y) and phosphorylated HMG-I, as modified by casein kinase II, using far Western and protein-protein interaction solution assays in the absence of CCAAT box DNA. Furthermore, the interaction between HMG-I(Y) and NF-Y was mapped to the highly conserved DNA binding-subunit interaction domain (DBD) of the NF-YA subunit and to a single AT-hook motif in HMG-I(Y). Recombinant HMG-I was also found to stabilize the CCAAT box DNA binding activity of recombinant NF-Y, as well as the native NF-Y complex, in vitro. Together, these results suggest a functional HMG-I(Y) protein binding site has been identified in the NF-Y complex and mapped to the conserved DBD and AT-hook regions of NF-YA and HMG-I(Y), respectively. This protein-protein interaction site may function to modulate NF-Y activity through stabilization of NF-Y binding to its CCAAT box DNA-binding site.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9388234     DOI: 10.1074/jbc.272.49.30880

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  Characterization of the human ephrin-A4 promoter.

Authors:  Else Munthe; Hans-Christian Aasheim
Journal:  Biochem J       Date:  2002-09-01       Impact factor: 3.857

2.  Functional phosphorylation sites in the C-terminal region of the multivalent multifunctional transcriptional factor CTCF.

Authors:  E M Klenova; I V Chernukhin; A El-Kady; R E Lee; E M Pugacheva; D I Loukinov; G H Goodwin; D Delgado; G N Filippova; J León; H C Morse; P E Neiman; V V Lobanenkov
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

3.  The role of HMG I(Y) in the assembly and function of the IFN-beta enhanceosome.

Authors:  J Yie; M Merika; N Munshi; G Chen; D Thanos
Journal:  EMBO J       Date:  1999-06-01       Impact factor: 11.598

4.  Architectural transcription factor HMGI(Y) promotes tumor progression and mesenchymal transition of human epithelial cells.

Authors:  R Reeves; D D Edberg; Y Li
Journal:  Mol Cell Biol       Date:  2001-01       Impact factor: 4.272

Review 5.  The HMG I proteins: dynamic roles in gene activation, development, and tumorigenesis.

Authors:  F Liu; K Y Chau; P Arlotta; S J Ono
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

6.  High-mobility-group protein I can modulate binding of transcription factors to the U5 region of the human immunodeficiency virus type 1 proviral promoter.

Authors:  A Henderson; M Bunce; N Siddon; R Reeves; D J Tremethick
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

7.  Protein kinase CK2 interacts with and phosphorylates the Arabidopsis circadian clock-associated 1 protein.

Authors:  S Sugano; C Andronis; R M Green; Z Y Wang; E M Tobin
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

8.  Recruitment of a repressosome complex at the growth hormone receptor promoter and its potential role in diabetic nephropathy.

Authors:  P M Gowri; J H Yu; A Shaufl; M A Sperling; R K Menon
Journal:  Mol Cell Biol       Date:  2003-02       Impact factor: 4.272

Review 9.  RNA-Mediated Regulation of HMGA1 Function.

Authors:  Arndt G Benecke; Sebastian Eilebrecht
Journal:  Biomolecules       Date:  2015

Review 10.  Anti-Transcription Factor RNA Aptamers as Potential Therapeutics.

Authors:  Estefanía Mondragón; Louis James Maher
Journal:  Nucleic Acid Ther       Date:  2015-10-28       Impact factor: 5.486

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.